ENTA vs HAL · rev $65.3M vs P/E 9.3, $19.05B cap
Enanta Pharmaceuticals Inc (ENTA) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
HAL does not have a complete income-statement cache yet.
ENTA currently screens at market cap $328.0M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ENTA and HAL stock pages for the full models.
Not investment advice.